S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

WNBA Star Sophie Cunningham Joins SHARx to Tackle Drug Costs

A viral on-court moment for Indiana Fever guard Sophie Cunningham has evolved into a platform for health advocacy. By joining the St. Louis-based company SHARx as a national brand ambassador, the Missouri native is shifting the spotlight from sports memes to the mounting crisis of prescription drug affordability.

WNBA Star Sophie Cunningham Joins SHARx to Tackle Drug Costs
Photo: Bio & News

The partnership centers on the company’s Rising Tides Army, an initiative that recruits athletes and public advocates to challenge the pharmaceutical status quo. For SHARx CEO Corey Durbin, the collaboration is a strategic move to move the conversation out of boardrooms and into households. By leveraging Cunningham’s reach, the firm aims to frame high medication costs as a direct threat to family budgets and business sustainability rather than a distant healthcare policy debate.

SHARx operates by assisting self-insured employers in navigating complex pharmacy benefit systems to lower costs. Durbin argues that the current industry model often leaves employees choosing between basic necessities and life-saving medication. By utilizing plain language and high-profile storytelling, the company hopes to demystify coverage rules and provide transparent, accessible alternatives to traditional, high-priced pharmacy plans.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!